Catheter Precision, Inc. (VTAK) - Form 8-K Summary
Business Context and Reporting Period
Catheter Precision, Inc., a Delaware corporation, filed this Current Report on Form 8-K on March 28, 2025. The filing announces the issuance of a press release detailing the Company's financial results for the fiscal year ended December 31, 2024. The Company's common stock trades on the NYSE American under the symbol VTAK.
Key Financial Metrics
The provided Form 8-K text serves as a notification of the results but does not contain specific numerical data. The filing states that the full text of the press release containing revenue, profit, cash flow, margins, debt, and liquidity metrics is attached as Exhibit 99.1. Consequently, the filing text does not provide a clear value for any specific financial metric.
Material Changes
As the specific financial figures are not included in the body of this 8-K, no material changes versus the prior comparable period can be identified from this document alone. Investors must refer to the attached press release (Exhibit 99.1) for comparative analysis.
Guidance, Outlook, and Risks
The filing does not contain management commentary, forward-looking guidance, specific risk factors, or details on contingencies within the main text. These items, if present, are located in the referenced press release. The filing includes a standard disclaimer that the information furnished in Item 2.02 and Exhibit 99.1 is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 and will not be incorporated by reference into other SEC filings unless expressly stated.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for actual revenue, net income, and cash flow figures for the year ended December 31, 2024.
- Verify year-over-year growth rates and margin trends in the attached press release.
- Check for any updated financial guidance or operational outlook provided in the press release.
- Confirm the status of the Company's liquidity and debt obligations as detailed in the full financial disclosure.